New applicator for cervical cancer radiation therapy
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new device called the ARCHITECT applicator for delivering brachytherapy (internal radiation) to people with locally advanced cervical cancer. The goal is to see if it is safe and feasible for routine use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cervical cancer that has spread locally (stage 1B3 to IVA).
- Your doctor has recommended primary radiation therapy, including brachytherapy.
- You are able to understand the study and give written permission (informed consent).
- The tumor does not extend into the lower two-thirds of the vagina.
- You do not need a specific size of applicator (13 mm) for the first treatment.
- You do not have a known allergy to nylon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether using CT scans to plan radiation treatment (brachytherapy) is as good as using MRI scans, for cervical cancer. If you join, you may receive standard radiation and chemotherapy, and the imaging method will be chosen randomly.
This trial is testing a combination of standard chemotherapy and radiation delivered to the pelvis, followed by an internal radiation treatment guided by CT scans. The goal is to improve treatment for locally advanced cervical cancer while potentially reducing side effects.
This trial tests whether an “adaptive” type of radiation planning using proton therapy and MRI-guided brachytherapy can improve treatment for people with cervical cancer. It aims to deliver curative treatment more precisely while still combining it with chemotherapy (cisplatin) when appropriate.
This trial tests whether a newer type of daily CT scan (CBCT-guided adaptive radiotherapy) can safely and accurately deliver radiation to cancers of the prostate, cervix, bladder, lung, or head and neck. The goal is to better target the tumor and reduce side effects.
This study is testing a special type of internal radiation (called image-guided brachytherapy) for women with vaginal cancer. It aims to give high doses directly to the tumor while limiting side effects to nearby organs.
This trial tests a custom 3D-printed applicator used during brachytherapy (internal radiation) for women with gynecologic cancers. It aims to deliver radiation more precisely to the tumor, possibly reducing side effects.
Hear when a new Locally Advanced Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.